Banque Pictet & Cie’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-14,090
| Closed | -$2.59M | – | 364 |
|
|
2021
Q2 | $2.59M | Sell |
14,090
-5,509
| -28% | -$1.01M | 0.03% | 185 |
|
|
2021
Q1 | $3M | Sell |
19,599
-600
| -3% | -$91.8K | 0.04% | 175 |
|
|
2020
Q4 | $3.16M | Sell |
20,199
-10,089
| -33% | -$1.58M | 0.04% | 167 |
|
|
2020
Q3 | $3.47M | Buy |
30,288
+12,307
| +68% | +$1.41M | 0.05% | 159 |
|
|
2020
Q2 | $2.02M | Sell |
17,981
-2,067
| -10% | -$232K | 0.03% | 189 |
|
|
2020
Q1 | $1.8M | Buy |
20,048
+608
| +3% | +$54.6K | 0.04% | 186 |
|
|
2019
Q4 | $2.1M | Buy |
19,440
+7,540
| +63% | +$815K | 0.04% | 199 |
|
|
2019
Q3 | $1.17M | Sell |
11,900
-330
| -3% | -$32.3K | 0.02% | 214 |
|
|
2019
Q2 | $1.6M | Sell |
12,230
-19,430
| -61% | -$2.55M | 0.03% | 193 |
|
|
2019
Q1 | $4.28M | Sell |
31,660
-18,185
| -36% | -$2.46M | 0.08% | 143 |
|
|
2018
Q4 | $4.85M | Sell |
49,845
-2,470
| -5% | -$240K | 0.1% | 132 |
|
|
2018
Q3 | $7.27M | Sell |
52,315
-6,973
| -12% | -$969K | 0.13% | 118 |
|
|
2018
Q2 | $7.36M | Sell |
59,288
-21,387
| -27% | -$2.66M | 0.14% | 110 |
|
|
2018
Q1 | $8.99M | Sell |
80,675
-545
| -0.7% | -$60.7K | 0.19% | 90 |
|
|
2017
Q4 | $9.71M | Buy |
81,220
+35,548
| +78% | +$4.25M | 0.19% | 76 |
|
|
2017
Q3 | $6.41M | Sell |
45,672
-10,948
| -19% | -$1.54M | 0.15% | 126 |
|
|
2017
Q2 | $6.89M | Buy |
56,620
+19,767
| +54% | +$2.41M | 0.16% | 107 |
|
|
2017
Q1 | $4.47M | Buy |
+36,853
| New | +$4.47M | 0.11% | 137 |
|